Friday, November 17, 2023 3pm to 4pm
About this Event
1945 Colorado Avenue, Boulder, CO 80309
Speaker: Dr. Becky Miller, NIH Program Leader
Abstract: The NIH Common Fund’s High-Risk, High-Reward Research program issues annual funding opportunities for exceptionally creative scientists with highly innovative research ideas. Learn about the NIH Director’s Pioneer, New Innovator, Transformative Research, and Early Independence Awards, supporting high-impact research from scientists at all career stages.
Biography: Dr. Becky Miller joined the Office of Strategic Coordination in 2014. She is a Program Leader managing the Illuminating the Druggable Genome program and Human Virome Program. She assists in programmatic management of the High-Risk, High-Reward Research program and oversees the NIH Director’s Early Independence Award. She did her postdoctoral work at the National Institute of Allergy and Infectious Diseases (NIAID) studying mosquito transmission of drug-resistant malaria. She earned her Ph.D. from the University of Notre Dame studying genomic variation in malaria parasites and was a GLOBES NSF IGERT fellow. She studied population genetics and phylogeography of mountain whitefish for her M.S. in molecular biology and received a B.S. in zoology, both from Brigham Young University.
0 people are interested in this event
User Activity
No recent activity
About this Event
1945 Colorado Avenue, Boulder, CO 80309
Speaker: Dr. Becky Miller, NIH Program Leader
Abstract: The NIH Common Fund’s High-Risk, High-Reward Research program issues annual funding opportunities for exceptionally creative scientists with highly innovative research ideas. Learn about the NIH Director’s Pioneer, New Innovator, Transformative Research, and Early Independence Awards, supporting high-impact research from scientists at all career stages.
Biography: Dr. Becky Miller joined the Office of Strategic Coordination in 2014. She is a Program Leader managing the Illuminating the Druggable Genome program and Human Virome Program. She assists in programmatic management of the High-Risk, High-Reward Research program and oversees the NIH Director’s Early Independence Award. She did her postdoctoral work at the National Institute of Allergy and Infectious Diseases (NIAID) studying mosquito transmission of drug-resistant malaria. She earned her Ph.D. from the University of Notre Dame studying genomic variation in malaria parasites and was a GLOBES NSF IGERT fellow. She studied population genetics and phylogeography of mountain whitefish for her M.S. in molecular biology and received a B.S. in zoology, both from Brigham Young University.
0 people are interested in this event
User Activity
No recent activity